Background Bloodstream infections caused by carbapenem-resistant Klebsiella pneumoniae (CRKP) in children pose a significant challenge to global public health and place tremendous pressure on clinical antibiotic treatment. A longitudinal retrospective study was designed to elucidate the clinical features, antibiotic resistance phenotypes, and molecular characteristics of CRKP isolated from bloodstream infections in children. Methods CRKP strains were collected from blood cultures over an eight-year period (2018–2025) at a tertiary children’s hospital in Beijing, China. Antimicrobial susceptibility testing and whole-genome sequencing (WGS) were performed to examine the resistance patterns and genetic diversity. Results CRKP bloodstream infections exhibited a distinct age-related pattern, with the highest incidence observed in infants younger than 3 months. Among the 91 isolates studied, none showed resistance to tigecycline or polymyxin B. The predominant carbapenemase genes identified were blaKPC-2 (52.7%) and blaNDM variants (40.7%), among which blaNDM-5 was the most prevalent. Strains carrying only blaKPC-2 were susceptible to ceftazidime/avibactam, whereas all strains harboring blaNDM genes demonstrated 100% resistance to this antibiotic. ST11–KL47(49.5%) was the predominant type and was strongly associated with blaKPC-2 and the 16S rRNA methyltransferase gene rmtB. Additionally, ST20–KL28 (15.4%) was prevalent and closely linked to blaNDM-5. Although ST11–KL64 (3.3%) constituted a minor proportion of isolates, all strains within this clone harbored notable virulence genes. Conclusion Pediatric CRKP bloodstream infections, predominantly affect young infants and are mediated primarily by blaKPC and blaNDM type carbapenemases. The dominant epidemic clones are ST11–KL47 and ST20–KL28, specifically linked to blaKPC-2 and blaNDM-5, respectively. Although ST11–KL64 accounted for only a limited proportion of the isolates, the virulence genes carried by this clone merit particular concern. These findings elucidate the molecular epidemiology of CRKP in children and provide a foundation for developing effective diagnostic, therapeutic, and preventive strategies.

Clinical and molecular characterizations of carbapenem-resistant Klebsiella pneumoniae among children with bloodstream infections in Beijing, China

期刊论文
出版模式：

开放获取
发表日期：

2026年7月14日

查看全文

Jing Li,
Zexuan Song,
Wenjian Xu,
Lin Zhou,
Li Yu,
Meng Tian,
Xin Zhang,
Lijuan Ma

摘要

Background

Bloodstream infections caused by carbapenem-resistant Klebsiella pneumoniae (CRKP) in children pose a significant challenge to global public health and place tremendous pressure on clinical antibiotic treatment. A longitudinal retrospective study was designed to elucidate the clinical features, antibiotic resistance phenotypes, and molecular characteristics of CRKP isolated from bloodstream infections in children.

Methods

CRKP strains were collected from blood cultures over an eight-year period (2018–2025) at a tertiary children’s hospital in Beijing, China. Antimicrobial susceptibility testing and whole-genome sequencing (WGS) were performed to examine the resistance patterns and genetic diversity.

Results

CRKP bloodstream infections exhibited a distinct age-related pattern, with the highest incidence observed in infants younger than 3 months. Among the 91 isolates studied, none showed resistance to tigecycline or polymyxin B. The predominant carbapenemase genes identified were bla_KPC-2 (52.7%) and bla_NDM variants (40.7%), among which bla_NDM-5 was the most prevalent. Strains carrying only bla_KPC-2 were susceptible to ceftazidime/avibactam, whereas all strains harboring bla_NDM genes demonstrated 100% resistance to this antibiotic. ST11–KL47(49.5%) was the predominant type and was strongly associated with bla_KPC-2 and the 16S rRNA methyltransferase gene rmtB. Additionally, ST20–KL28 (15.4%) was prevalent and closely linked to bla_NDM-5. Although ST11–KL64 (3.3%) constituted a minor proportion of isolates, all strains within this clone harbored notable virulence genes.

Conclusion

Pediatric CRKP bloodstream infections, predominantly affect young infants and are mediated primarily by bla_KPC and bla_NDM type carbapenemases. The dominant epidemic clones are ST11–KL47 and ST20–KL28, specifically linked to bla_KPC-2 and bla_NDM-5, respectively. Although ST11–KL64 accounted for only a limited proportion of the isolates, the virulence genes carried by this clone merit particular concern. These findings elucidate the molecular epidemiology of CRKP in children and provide a foundation for developing effective diagnostic, therapeutic, and preventive strategies.